Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis ... (RedNova)
Affymax, Inc. (Nasdaq:AFFY) today announced that results available from its Phase 2 clinical trial of Hematide dosed monthly in dialysis patients were presented this week at the National Kidney Foundation (NKF) 2007 Spring Clinical Meeting.

Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets (PR Newswire via Yahoo! Finance)
Ohm Laboratories Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg.